[New drug treatment for age-related macular degeneration]
[Article in
Icelandic]
Affiliations
- PMID: 17460341
Item in Clipboard
[New drug treatment for age-related macular degeneration]
[Article in
Icelandic]
Laeknabladid.
2007 Apr.
Abstract
New drugs for age-related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with age-related macular degeneration.
Similar articles
-
Controversies in the treatment of wet age-related macular degeneration.Am J Ophthalmol. 2008 May;145(5):937; author reply 938. doi: 10.1016/j.ajo.2008.02.021. Am J Ophthalmol. 2008. PMID: 18435977 No abstract available.
-
Intravitreal bevacizumab.Ophthalmology. 2007 Feb;114(2):400; author reply 400-1. doi: 10.1016/j.ophtha.2006.10.002. Ophthalmology. 2007. PMID: 17270701 No abstract available.
-
Charles Bonnet syndrome (visual hallucinations) after intravitreal avastin injection for age-related macular degeneration.Am J Ophthalmol. 2007 Aug;144(2):330; author reply 330-1. doi: 10.1016/j.ajo.2007.04.002. Am J Ophthalmol. 2007. PMID: 17659977 No abstract available.
-
Avastin and new treatments for AMD: where are we?Retina. 2006 Oct;26(8):853-8. doi: 10.1097/01.iae.0000244722.35073.7c. Retina. 2006. PMID: 17031283 Review. No abstract available.
-
Emerging therapies for the treatment of wet age-related macular degeneration--VEGF Trap-Eye.Klin Oczna. 2011;113(10-12):376-8. Klin Oczna. 2011. PMID: 22384659 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical